Bial R&d Investments, S.a.

This study is testing whether an investigational drug called BIA 28-6156 can slow the worsening of movement problems in people with Parkinson's disease who have a specific genetic change in the GBA1 gene. About 237 participants will take either the drug at one of two doses or a p…